US Reps. Alexandria Ocasio-Cortez and Jan Schakowsky on Thursday sent letters to the two potential buyers of troubled genetic testing firm 23andMe demanding details about consumer data privacy should either of them acquire the company. Signed by 20 other Democratic members of Congress, the letters were sent to Regeneron Pharmaceuticals …
Read More »
Brain-computer-interface startup Paradromics today announced that surgeons successfully inserted the company’s brain implant into a patient and safely removed it after about 10 minutes. It’s a step toward longer trials of the device, dubbed Connexus. It’s also the latest commercial development in a growing field of companies—including Elon Musk’s Neuralink—aiming …
Read More »
The Enhanced Games—a kind of Olympics for athletes who are doping—today announced the date and venue for its first competition: May 21-24, 2026, at Resorts World Las Vegas. Athletes competing in the event will be allowed to take performance-enhancing drugs like testosterone and anabolic steroids that are usually banned from …
Read More »
The FDA gave compounders a grace period to wind down their production of the drugs after the shortage was over. Small pharmacies had until February 18 to comply, while larger outsourcing facilities had until March 19. (Semaglutide compounders were ordered to cease mass production this spring, with smaller compounders given …
Read More »